Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Takeda introduces enteropeptidase inhibitors

Sep. 3, 2015

Dicerna Pharmaceuticals submits IND application to FDA for DCR-PH1

Sep. 3, 2015

Viking Therapeutics begins trial of VK-5211 for acute hip fracture

Sep. 3, 2015

Strensiq launched in Japan for hypophosphatasia

Sep. 2, 2015

Lipocine files U.S. NDA for testosterone replacement therapy LPCN-1021

Sep. 1, 2015

European approval of Strensiq for pediatric-onset hypophosphatasia

Sep. 1, 2015

Initial results reported from phase I trial of RNAi therapeutic ALN-PCSsc

Sep. 1, 2015

First oral agent for Gaucher's disease launched in Japan

Sep. 1, 2015

Kanuma becomes first approved treatment in E.U. for LAL-D

Sep. 1, 2015

Teijin Pharma reports development of novel xanthine oxidase inhibitors

Sep. 1, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...